Artivion, Inc. (NYSE:AORT) Q1 2025 Earnings Call Transcript
Operator: Greetings. Welcome to Artivion's First Quarter 2025 Financial Conference Call. At this time, all participants are in listen-only mode.
Artivion Inc. (AORT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 687,420 | $16,896,784 | -18% | 0.18% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.25 | 600 | Director | 600 | 2025-03-05 | Filing | |
| $25.33 | 1,500 | Director | 35,659 | 2025-03-05 | Filing | |
| $17.33 | 600 | Officer | 72,499 | 2021-11-29 | Filing | |
| $17.36 | 15,000 | Director | 19,992 | 2021-11-29 | Filing | |
| $16.74 | 7,500 | Officer | 264,274 | 2020-09-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.61 | 18,020 | Officer | 197,184 | 2025-03-11 | Filing | |
| $23.61 | 15,100 | Officer | 208,778 | 2025-03-11 | Filing | |
| $24.76 | 70,700 | Officer | 865,283 | 2025-03-06 | Filing | |
| $24.80 | 17,739 | Officer | 860,368 | 2025-03-06 | Filing | |
| $24.80 | 1,048 | Officer | 146,651 | 2025-03-06 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,202,731 | $152,463,118 | 0% | |
| 2. | 2,782,007 | $68,381,733 | 0% | |
| 3. | 132,672 | $32,610,778 | 0.05% | |
| 4. | 14,790 | $16,557,405 | 0.64% | |
| 5. | 376,052 | $9,243,358 | 0% |
News See All
Artivion, Inc. (NYSE:AORT) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Artivion Fourth Quarter and Year End 2024 Financial Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Billionaire Joseph Edelman's Top 10 Long-Term Stock Picks
Joseph Edelman is a renowned figure in the investment world, recognized for his expertise in biotechnology and healthcare investing.
Artivion, Inc. (NYSE:AORT) Q3 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Artivion Third Quarter 2024 Financial Conference Call. At this time, all participants are in listen only mode.
Should You Invest in Artivion (AORT)?
Next Century Growth Investors, LLC, an investment Management Company, released its “Small Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Artivion, Inc. (NYSE:AORT) Q2 2024 Earnings Call Transcript
Operator: Greetings. And welcome to Artivion’s Second Quarter 2024 Financial Conference Call. At this time, all participants are on a listen-only mode.
Do You Think Artivion (AORT) Stock Could Soar?
Wasatch Global Investors, an asset management company, released its “Wasatch Micro Cap Growth—U.S. Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Artivion, Inc. (NYSE:AORT) Q1 2024 Earnings Call Transcript
Artivion, Inc. beats earnings expectations. Reported EPS is $0.1573, expectations were $0.02.
Artivion, Inc. (NYSE:AORT) Q4 2023 Earnings Call Transcript
Artivion, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.13. Artivion, Inc.
Artivion, Inc. (NYSE:AORT) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Artivion Third Quarter 2023 Financial Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
